Log In
BCIQ
Print this Print this
 

BL-1220

  Manage Alerts
Collapse Summary General Information
Company BioLineRx Ltd.
DescriptionOral formulation of sodium alginate
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Hepatic (unspecified)
Indication DetailsTreat liver failure conditions
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/23/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today